Status:

COMPLETED

PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS

Lead Sponsor:

University of Colorado, Denver

Conditions:

Diabetic Foot Ulcer

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Study Objective: The objective of this Phase 1 open-label study is to establish the safety and tolerability of Corlicyte mesenchymal stem cells (MSCs) in the treatment of patients with chronic diabet...

Eligibility Criteria

Inclusion

  • Males or non-pregnant, non-lactating females.
  • Age 18 or greater at the time of informed consent.
  • Able and willing to provide written informed consent.
  • Type 1 or Type 2 diabetes.
  • Chronic DFU as the index ulcer meeting all of the following criteria:
  • present for at least 4 weeks at the time of Screening Visit 1
  • located below the malleoli of the foot
  • extends to the dermis or subcutaneous tissue, surrounded by healthy skin, without evidence of exposed muscle, tendon, bone, or joint capsule
  • area measures 1 to 10 cm2 inclusive, at Screening Visit 1, and
  • non-healing (defined as ≤50% reduction in ulcer size by the Baseline Visit, as compared to Screening Visit 1).
  • Negative for antibodies to HLA Class I molecules expressed on Corlicyte MSCs, as measured by Luminex HLA single antigen beads, within 3 months prior to start of Treatment Phase without interval sensitizing events.
  • For an index ulcer on the plantar surface of the foot, willingness to offload the foot per study protocol.
  • In women of childbearing potential, willingness to use effective means of birth control during the course of the study; if using systemic birth control, this must have been used for 6 months or longer prior to Screening Visit 1.

Exclusion

    Key Trial Info

    Start Date :

    November 12 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2023

    Estimated Enrollment :

    16 Patients enrolled

    Trial Details

    Trial ID

    NCT04104451

    Start Date

    November 12 2019

    End Date

    August 1 2023

    Last Update

    January 29 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Colorado Anschutz Medical Campus

    Aurora, Colorado, United States, 80045